Evaluation of alloimmune responses in humanised NOD/SCID/IL2Rgnull mice following human CD34+stem cell transplantation

被引：0
|
作者：
Hartwig, U. F. [1 ]
Nonn, M. [1 ]
Khan, S. A. [1 ]
Brunk, A. [1 ]
Hemmerling, J. [1 ]
Meyer, R. G. [1 ]
Andre, M. C. [2 ]
Handgretinger, R. [2 ]
Huber, C. [1 ]
Herr, W. [1 ]
机构：
[1] Johannes Gutenberg Univ Mainz, Mainz, Germany
[2] Univ Tubingen, Tubingen, Germany
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [1] EVALUATION OF ALLOIMMUNE RESPONSES IN HUMANIZED NOD/SCID/IL2RGNULL MICE FOLLOWING HUMAN CD34+ STEM CELL TRANSPLANTATION
    Hartwig, U. F.
    Hemmerling, J.
    Hoffmann, J.
    Andre, M. C.
    Handgretinger, R.
    Huber, C.
    Herr, W.
    Meyer, R. G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 130 - 130
  • [2] Evaluation of human NK cell responses to PDX tumors in humanized NOD-scid IL2rgnull (NSG) mice expressing human IL15
    Aryee, Ken-Edwin
    Burzenski, Lisa
    Greiner, Dale L.
    Whalen, Giles F.
    Yao, Li-Chin
    Shultz, Leonard D.
    Keck, James G.
    Brehm, Michael A.
    CANCER RESEARCH, 2019, 79 (13)
  • [3] Comparison of biological features between severely immuno-deficient NOD/Shi-scid Il2rgnull and NOD/LtSz-scid Il2rgnull mice
    Nagatani, Mariko
    Kodera, Tsutomu
    Suzuki, Daisuke
    Igura, Saori
    Fukunaga, Yachiyo
    Kanemitsu, Hiroyuki
    Nakamura, Daichi
    Mochizuki, Masahiro
    Kemi, Masayuki
    Tamura, Kazutoshi
    Kasahara, Kenichiro
    EXPERIMENTAL ANIMALS, 2019, 68 (04) : 471 - 482
  • [4] Decitabine enhances targeting of AML cells by CD34+ progenitor-derived NK cells in NOD/SCID/IL2Rgnull mice
    Cany, Jeannette
    Roeven, Mieke W. H.
    Evert, Janneke S. Hoogstad-van
    Hobo, Willemijn
    Maas, Frans
    Fernandez, Rosalia Franco
    Blijlevens, Nicole M. A.
    van der Velden, Walter J.
    Huls, Gerwin
    Jansen, Joop H.
    Schaap, Nicolaas P. M.
    Dolstra, Harry
    BLOOD, 2018, 131 (02) : 202 - 214
  • [5] Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice
    Suemizu, Hiroshi
    Hasegawa, Masami
    Kawai, Kenji
    Taniguchi, Kenji
    Monnai, Makoto
    Wakui, Masatoshi
    Suematsu, Makoto
    Ito, Mamoru
    Peltz, Gary
    Nakamura, Masato
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 377 (01) : 248 - 252
  • [6] CD34+ progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rgnull mice
    van der Meer, Jolien M. R.
    de Jonge, Paul K. J. D.
    van der Waart, Anniek B.
    Geerlings, Alexander C.
    Moonen, Jurgen P.
    Brummelman, Jolanda
    de Klein, Janne
    Vermeulen, Malou C.
    Maas, Ralph J. A.
    Schaap, Nicolaas P. M.
    Hoogstad-van Evert, Janneke S.
    Ottevanger, Petronella B.
    Jansen, Joop H.
    Hobo, Willemijn
    Dolstra, Harry
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [7] Transgenic expression of human IL15 in NOD-scid IL2rgnull (NSG) mice enhances the development and survival of functional human NK cells
    Brehm, Michael A.
    Aryee, Ken-Edwin
    Bruzenksi, Lisa
    Greiner, Dale L.
    Shultz, Leonard D.
    Keck, James
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [8] Application of germ-free NOD-scid IL2rgnull mice as a humanized model for tumor microbiome precision medicine
    Wu, Chengwei
    Shang, Haitao
    Jiang, Xianhong
    Wang, Xinning
    Wei, Hong
    SCIENCE CHINA-LIFE SCIENCES, 2021, 64 (04) : 644 - 647
  • [9] NovelNOD-scid IL2rgnull(NSG)mice for preclinical evaluation of TLR agonists in cancer immunotherapy
    Aryee, Ken -Edwin
    Burzenski, Lisa
    Greiner, Dale
    Whalen, Giles F.
    Shultz, Leonard
    Keck, James
    Brehm, Michael
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Transgenic expression of human IL15 in NOD-scid IL2rgnull (NSG) mice enhances the development and survival of functional human NK cells
    Aryee, Ken-Edwin
    Burzenski, Lisa
    Greiner, Dale L.
    Welsh, Raymond M.
    Shultz, Leonard D.
    Keck, James G.
    Brehm, Michael A.
    CANCER RESEARCH, 2018, 78 (13)
12345